Innovations in Immunology 2019
-
Combining vaccines and checkpoint blockades to fight cancer
Immunotherapy is a type of cancer treatment that harnesses the body’s own immune system to kill tumours. It has already dramatically improved the outlook for certain types of cancer, particularly in patients who have become resistant to standard treatments, such as chemotherapy. Cytotoxic T-lymphocytes (or killer T cells) usually detect damaged cells or those infected...
-
Drug resistance is a constant threat to progress in HIV, TB and malaria vaccines
HIV/AIDS, tuberculosis (TB), and malaria are three major infections that globally lead to approximately five million deaths every year, with the majority of these occurring in sub-Saharan Africa. Despite global efforts at prevention and improving control, the public health impact of these diseases is still huge. Medicines are the mainstay of control efforts, but drug...
-
Immunology at the cutting-edge
Immunology is trailblazing a path of medical discovery. What are the emerging areas that experts think will have a significant impact on our ability to treat disease? Immunology is at the cutting-edge of medical discovery, with many new biological agents now translating from bench to bedside. As our understanding of how the immune system functions...
-
What does immunology need to succeed?
Immunology is at the cutting-edge of our knowledge of how the body works. But how can we create the right environment to allow immunology research to thrive and translate into life-changing impact for patients? The field of immunology is expanding at a significant rate, spreading its influence into many new disciplines and helping us better...
-
How to translate discoveries into treatments fast
Ensuring patients receive the benefits of ground-breaking basic science discoveries as quickly as possible requires intellectual and technological collaboration. The latest hot topic in immuno-oncology – following checkpoint inhibitors – is CAR-T cell therapy. It went from the very first research publication in 1989, through development and into clinic in under 20 years. Mario Assenmacher,...
-
Checkpoint inhibitory receptors keep the immune system in check
Pictured: Professor Andreas Radbruch, President of the European Federation of Immunological Societies (EFIS) This is an opinion piece and the source has had no input to any other content in this campaign Cancer checkpoint blockade – this year’s Day of Immunology theme – has revolutionised cancer treatment for many patients. Every year on April 29th,...
-
Time for the single-cell revolution
We are standing on the cusp of a “single-cell revolution” that could increase our understanding of the immune system exponentially. The technology, developed by 10x Genomics, allows scientists to analyse the antigen receptors of an individual T-cell, uncover which proteins are on the cell’s surface, and ‘match’ the antigens that will attach to it. “This...
-
From basic to translational immunology, and back
Faith Osier and Clive Gray will co-chair the 18th IUIS Congress of Immunology in Cape Town in 2022. Africa has never before hosted such a meeting and being the cradle of humankind, immunology in Africa is a blend of ancient roots with cutting edge science. The combination of a high burden of communicable and non-communicable...
Health Awareness
